Amyotrophic Lateral Sclerosis Clinical Trials in New York, New York

9 studies are recruiting for amyotrophic lateral sclerosis in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

   The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the safety of pridopidine. The main question it aims to answer is: Does pridopidine slow disease progression of ALS? Researchers will compare …

   Stage

   Phase 3

   Ages

   18 to 80

   Site

   Eleanor and Lou Gehrig ALS Center at Columbia University, New York, New York

   Locations

   55 in total

   Run by

   Prilenia

   See if you can join NCT07322003 on ClinicalTrials.gov

2. Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

   PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evaluate the safety, tolerability and effects on clinical and biomarker endpoints of intracisternal administration of Vtx-002 in participants with Amyotrophic Lateral Sclerosis (ALS). T…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Herbert Irving Comprehensive Cancer Center, New York, New York

   Locations

   11 in total

   Run by

   Vector Y Therapeutics

   See if you can join NCT07287397 on ClinicalTrials.gov

3. ASSESS ALL ALS Study

   The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is being funded by the National Institutes of Heal…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University, New York, New York

   Locations

   37 in total

   Run by

   St. Joseph's Hospital and Medical Center, Phoenix

   See if you can join NCT06578195 on ClinicalTrials.gov

4. PREVENT ALL ALS Study

   The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is begin funded by the National Institutes of Heal…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University, New York, New York

   Locations

   32 in total

   Run by

   St. Joseph's Hospital and Medical Center, Phoenix

   See if you can join NCT06581861 on ClinicalTrials.gov

5. ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

   ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University, New York, New York

   Locations

   27 in total

   Run by

   Mayo Clinic

   See if you can join NCT04363684 on ClinicalTrials.gov

6. Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

   The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (ALS).

   Stage

   Phase 2

   Ages

   18 and older

   Site

   353, New York, New York

   Locations

   35 in total

   Run by

   Corcept Therapeutics

   See if you can join NCT05407324 on ClinicalTrials.gov

7. Clinical Procedures to Support Research in ALS

   The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University, New York, New York

   Locations

   11 in total

   Run by

   University of Miami

   See if you can join NCT03489278 on ClinicalTrials.gov

8. Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

   The goal of the study is to generate a biorepository of longitudinal biofluids-blood (plasma and serum), cerebral spinal fluid (CSF) and urine linked to genetics and longitudinal clinical information that are made available to the research community. To accomplish these goals, we will enroll 800 Am…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University, New York, New York

   Locations

   12 in total

   Run by

   Target ALS Foundation, Inc.

   See if you can join NCT05137665 on ClinicalTrials.gov

9. NYSCF Scientific Discovery Biobank

   The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…

   Stage

   Not phased

   Ages

   0 and older

   Site

   New York Stem Cell Foundation Research Institute, New York, New York

   Run by

   New York Stem Cell Foundation Research Institute

   See if you can join NCT06203106 on ClinicalTrials.gov